Professor, Department of Medicine, McGill University

Topic: Novel tyrosine kinase combinations and their associated toxicities

Wilson H. Miller, Jr. is the Distinguished James McGill Professor in the Departments of Oncology and Medicine at McGill University, Montreal. He is Associate Director of the Lady Davis Institute, Deputy Director of the Segal Cancer Center. Dr. Miller has a PhD from The Rockefeller University and an MD from Cornell University Medical College. He has held a faculty appointment in the Department of Medicine at Cornell and at the Memorial Sloan-Kettering Cancer Center in New York. Dr. Miller’s laboratory at the Lady Davis Institute investigates molecular mechanisms underlying breast cancer and melanoma, with a focus on pathways regulating protein synthesis, modification and degradation, as well as the role of these pathways in modifying the tumor immune microenvironment. Dr. Miller has received a number of research awards throughout his career, including the Medical Research Council of Canada Scientist Award and the FRSQ Chercheur National Award. Dr. Miller is a well-known speaker at national and international meetings and sits on peer review panels for the National Institutes of Health (US), the Canadian Institute of Health Research, the Ontario Cancer Research Network, and the Canadian Cancer Society. In his role as Director of Phase 1 studies at McGill, he has had a leading role in the development of immuno-oncology. As past Clinical Lead of the Rossy Cancer Network — a partnership dedicated to integrating and improving quality of care in the McGill University-affiliated hospitals — Dr. Miller spearheaded the implementation of a multi-hospital disease site program and promoted collaboration between clinical trials throughout the network.